Skip to main content
CK Life Sciences Int'l., (Holdings) Inc. logo

CK Life Sciences Int'l., (Holdings) Inc. — Investor Relations & Filings

Ticker · 775 ISIN · KYG2176J1058 LEI · 529900VUJHPZ88D3MO15 HKEX Manufacturing
Filings indexed 2,936 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 775

About CK Life Sciences Int'l., (Holdings) Inc.

http://www.ck-lifesciences.com

CK Life Sciences Int'l., (Holdings) Inc. is an investment holding company dedicated to improving the quality of life through biotechnology. It focuses on the research, development, manufacturing, commercialization, and sale of products in two primary areas: human health and environmental sustainability. The human health segment includes nutraceuticals, health supplements, and healthcare R&D initiatives. The environmental sustainability segment encompasses agriculture-related products, such as fertilizers and crop protection solutions. The company markets its portfolio across North America, Australia, and Asia, utilizing proprietary R&D and patented inventions. It operates as a member of the CK Hutchison Group.

Recent filings

Filing Released Lang Actions
ANNUAL GENERAL MEETING HELD ON 21ST MAY, 2026 - POLL RESULTS
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement by CK Life Sciences of the poll results for resolutions passed at its Annual General Meeting held on 21 May 2026. It lists each resolution, vote counts “For” and “Against,” and confirms the resolutions were duly passed. This clearly fits the category of a declaration of voting results at a general meeting (AGM), matching code DVA.
2026-05-21 English
List of Directors and their Roles and Functions
Regulatory Filings
2026-05-08 English
RESIGNATION OF EXECUTIVE DIRECTOR, VICE PRESIDENT AND CHIEF EXECUTIVE OFFICER AND RE-DESIGNATION OF EXECUTIVE DIRECTOR
Regulatory Filings
2026-05-08 English
Monthly Return for Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return report for an equity issuer listed on the Hong Kong Exchange, detailing movements in authorised share capital, issued shares, treasury shares, and public float sufficiency confirmation for the month ended 30 April 2026. It includes no financial statements, earnings data, or management discussion, but focuses on share capital and shareholding structure movements. This type of document is a regulatory filing related to share capital and public float compliance, typically submitted to the exchange as part of ongoing disclosure obligations. It does not constitute an annual report, interim report, earnings release, or any other specific report type but is a regulatory compliance filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-05-05 English
Sustainability Report 2025
Environmental & Social Information Classification · 95% confidence The document is titled 'SUSTAINABILITY REPORT 2025' and contains detailed sections on environmental progress, social responsibility, corporate governance, and sustainability governance. It discusses climate-related risks, environmental targets, social and human capital management, and ESG governance. There is no indication that this is an annual financial report, earnings release, or regulatory filing. The content focuses on Environmental, Social, and Governance (ESG) factors and sustainability performance indicators. Therefore, the document fits the category of Environmental & Social Information (SR). The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement or summary.
2026-04-17 English
Notice of Annual General Meeting
AGM Information Classification · 100% confidence The document is a detailed notice of the Annual General Meeting (AGM) for CK Life Sciences Int'l. (Holdings) Inc. It includes the date, location, agenda items such as receiving audited financial statements, election of directors, appointment of auditors, and resolutions related to directors' fees and share issuance mandates. The document also contains procedural notes about proxy voting, bad weather arrangements, and shareholder eligibility. There is no actual financial data or report content included, only the announcement and details about the upcoming AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.